Novo Nordisk’s Post

We’re on a mission to drive change for millions of people living with chronic diseases and we need talents to help shape the future.   Did you know that we currently have around 1,000 open positions across the world? Check out our career site to see if there is a match for you: https://lnkd.in/dfHdaYP #NovoNordisk #DrivingChange #Career

It takes more than medicine to defeat chronic diseases.   It takes sport, song, culture, collaboration, listening and partnership. Just ask these inspiring people who are making big changes to the health of their communities - each in their own unique way. #NovoNordisk #DrivingChange #Health

Missed anything from #ISTH2024? Catch up on the exciting updates from the International Society on #Thrombosis and #Haemostatis at Novo Nordisk CongressHub 👉 https://bit.ly/45rxuxI

28 June marks the anniversary of the pivotal Stonewall uprising in 1969, which ignited the modern LGBTQ+ rights movement.   We have partnered with Stonewall to focus on everyday inclusion for our LGBTQ+ colleagues, fostering an environment where everyone can thrive. To kick off the partnership, we are joining their Rainbow Laces campaign, which aims to spark dialogue around how we can all become active allies for LGBTQ+ inclusion, both in the workplace and in making sport everyone's game.    The ask is simple – lace up to speak up!   Learn more abut our partnership here: https://lnkd.in/dfT5m4AS

The only way we can overcome low awareness of #sicklecelldisease and the stigmas faced by people living with it is by starting more conversations. This #WorldSickleCellDay we’re asking you to join us in raising awareness. Have one conversation with one other person about Sickle Cell Disease today. You can learn more about it here: https://lnkd.in/dM-YdTN We are committed to a future where it is possible to #liveunlimited with sickle cell disease, are you? #WorldSickleCellDay #WSCD2024

Exciting developments are underway at our production site in Chartres, France!   This week, members of our leadership team and board visited the site to see how we’re investing in and significantly expanding our facilities to meet the needs of millions of people living with diabetes, obesity, and other serious chronic diseases. By 2028, we aim to welcome 500 new colleagues, and increase our capacity to serve many more patients.   A special thanks to our 1700 dedicated colleagues at Chartres, who produce life-saving treatments.

Did you know? MASH, or metabolic dysfunction-associated steatohepatitis, is a serious, progressive, metabolic disease affecting the liver, which can be fatal if not managed properly. It is often described as a ‘silent disease’ due to the lack of specific symptoms in the early stages of the disease, which often contributes to a delay in diagnosis. 13 June is Global #FattyLiverDay 🌎 Learn more about living with the condition and the impact of a late diagnosis from Tania. Watch Tania’s story here: https://lnkd.in/dAw55qZV At Novo Nordisk, we are committed to continuing our research with the ambition of developing innovations that can help address the underlying cause of this disease. We hope to double diagnostic rates for people living with moderate to advanced MASH by 2027 💙

The count down is on and we're looking forward to #ISTH2024 in Bangkok! Follow along online between 22 - 26 June as we address the unmet needs in haemophilia, and raise awareness of rare diseases 👇 https://bit.ly/4bYBdoI #ChangingHaemophilia

Have you ever heard of the chronic disease, MASH? It is a progressive, chronic, metabolic liver disease that impacts more than 250 million people globally. It is often described as a ‘silent disease’ due to lack of symptoms and lack of awareness – all contributing to a delay in diagnosis. Thousands of liver specialists are at the #EASLCongress2024 in Milan to highlight new developments in MASH. We are looking forward to engaging peers from around the world, as we advance the science to help people living with this progressive disease. To learn more about MASH, click here: https://lnkd.in/dzRkrH8N #EASLCongress2024 #drivingchange #ActOnMASH